Brazil’s public health system begins offering fecal immunochemical test (FIT) screening for colorectal cancer in December, targeting asymptomatic adults aged 50 to 75 every two years — even as diagnoses climb sharply among younger adults, a gap specialists attribute to balancing lives saved against limited colonoscopy capacity, UOL reported.
The launch answers a question many readers are asking after the deaths of singer Preta Gil in 2025 at 50 and actress Lua Blanco this year at 39: if young people are getting bowel cancer, why does screening start so late?
The answer, specialists told UOL, lies in epidemiology and economics. Health authorities set screening ages by weighing how many people in each age band develop the disease, how many die, how many lives earlier testing would save, and what risks the procedures themselves carry.
The Brazil rollout is the country’s first organized colorectal cancer screening program in the public system. According to Estadão, the Health Ministry announced the FIT test would enter the SUS procedure table in August, with delivery beginning in December.
The ministry targets a population of about 51 million people aged 50 to 75, per IBGE figures cited by Estadão — but only 400,000 tests will be delivered immediately, deputy director of the ministry’s cancer care department Flavia Kelli Alvarenga Pinto said at the Brazilian Society of Clinical Oncology congress on November 7.
“Fazer rastreamento de 50 anos para cima já é um desafio num país como o Brasil. A gente já tem filas de espera enormes, às vezes inclusive no setor privado, esperando colonoscopias,” said Samuel Aguiar Jr., leader of the Colorectal Tumor Reference Center at A.C.Camargo Cancer Center, in remarks translated from Portuguese: screening from age 50 upward is already a challenge in a country like Brazil, with enormous waiting lists — sometimes even in the private sector — for colonoscopies, according to UOL.

“Você quer salvar a maior quantidade de vidas possível dentro dos recursos que você tem disponíveis,” Aguiar told UOL — you want to save the greatest number of lives possible within the resources available.
FIT test detects hidden blood in stool at home
- The FIT test detects tiny, invisible amounts of blood in stool — an early warning sign of polyps or bowel cancer. It is done at home, requires no diet change or bowel preparation, and is repeated every two years if negative.
- A positive FIT result is not a cancer diagnosis. It triggers a referral for colonoscopy, the definitive exam that can both find and remove precancerous polyps.
- Screening ages apply to people without symptoms. Anyone with rectal bleeding, unexplained weight loss, abdominal pain, anemia, or a change in bowel habits should see a doctor regardless of age.
Medical societies lowered starting age to 45
Several medical societies — including the Brazilian Society of Coloproctology and, in 2018, the American Cancer Society — have lowered their recommended starting age from 50 to 45, driven by rising cases in younger adults. The SUS protocol remains at 50. Aguiar explained the calculus to UOL: lowering it further would multiply referrals for colonoscopy among people without symptoms, in a system already struggling to clear its queue.
Danilo Munhóz, a coloproctologist at the Clínica Primazo and member of the Brazilian Society of Coloproctology, told UOL that recommendations weigh how many people develop the disease, how many die, how many lives earlier exams would save — and the risks of the procedures themselves.
Colonoscopy requires bowel preparation and sedation and carries small procedural risks, which is why most public programs worldwide use the stool test as a first filter rather than scoping everyone.
The rise in early-onset colorectal cancer
The concern is real and quantified. An A.C.Camargo Cancer Center study of 5,559 cases diagnosed between 2000 and 2023 found cases rising by 8.5% per year among Brazilians aged 30 to 39, and 7.6% per year among adults under 50, according to coverage carried by Gente Seguradora.
In the United States, a University of Chicago study published via ScienceDaily on November 12 found the national rate rose to 38.3 cases per hundred thousand people in 2023, up from 36.7 in 2022 — with cases among 45- to 49-year-olds growing 12.76% per year from 2019 to 2023, the steepest rise of any age group studied.
Oncologist Nildevande Firmino told Rádio Folha’s Canal Saúde that generational risk has shifted markedly: people born around the 1990s face roughly double the colon cancer risk and four times the rectal cancer risk of a generation born in the mid-1950s at the same age.
She linked the trend to dietary and behavioral changes — processed meat, red meat, obesity, and smoking. Citing the WHO’s cancer research classification, she said that 50 grams of processed meat daily — about two slices of ham or one sausage — is associated with roughly an 18% increase in colorectal cancer risk.
The INCA, Brazil’s national cancer institute, classifies colorectal cancer as one of the most prevalent in the country, with around 45 thousand new cases per year — most caught at an advanced stage, Firmino said. About 60% of cases arrive with advanced disease, she said, while early detection pushes cure rates above 90%. In some cases, she added, removing a precancerous lesion during colonoscopy alone cures the patient, with no surgery or chemotherapy.
How the SUS rollout will work
From December, teams at basic health units (UBS) will identify and invite people in the target group, Estadão reported. Patients receive a container to collect a stool sample at home or at the unit.
FIT was chosen over colonoscopy as the entry test because it is less invasive, requires no bowel preparation, and has an accuracy rate between 85% and 92%, per Estadão. A positive result leads to colonoscopy; a negative one, to repeat testing in two years.
The initial offer will be geographically limited. The ministry told Estadão it suggested states phase in the program in territories that have colonoscopy capacity — because, as Pinto put it, there is no point deploying the test where patients cannot be followed up.
Coloproctologist Tiago Ghezzi, quoted by Correio do Povo, welcomed the FIT’s accuracy and the access it opens — the ministry says it could reach more than 40 million Brazilians — but stressed the test does not replace colonoscopy.
| Measure | Detail |
|---|---|
| SUS target population | Asymptomatic adults, 50–75 years |
| FIT accuracy | 85%–92% (per Estadão) |
| Initial delivery | 400,000 tests from December, out of ~51 million eligible |
| Positive result | Referral for colonoscopy |
| Medical societies’ recommendation | Colonoscopy from age 45 (SBCP; American Cancer Society since 2018) |
What remains unresolved
The drivers of the surge in early-onset disease remain under investigation. University of Chicago researchers told ScienceDaily that part of the US increase may reflect earlier screening detecting more tumors, but rises appeared even among people aged 65 to 69.
Ghezzi cited by Correio do Povo pointed to possible contributors including pesticide and herbicide contamination of food and ingestion of nanoplastics — hypotheses, not established causes. His practical warning: young patients tend to dismiss symptoms because they fall outside the screening age band, delaying diagnosis until disease is advanced.
Family history changes the picture. Firmino told Rádio Folha that people with a first-degree relative diagnosed with colon cancer should begin colonoscopy about ten years before the age at which that relative was diagnosed.
Symptomatic people should seek colonoscopy, not screening
The FIT screening program is designed for people without symptoms. Per the Health Ministry guidance reported by Estadão, anyone with blood in the stool, abdominal pain, unexplained weight loss, or a change in bowel habits should not wait for an invitation to screening — they should seek medical evaluation for possible direct colonoscopy, at any age.
Unexplained anemia likewise warrants investigation, Ghezzi told Correio do Povo. People under 45 should not ignore warning signs simply because routine screening has not reached their age bracket, the University of Chicago researchers cautioned via ScienceDaily. FIT is not a substitute for colonoscopy, which remains the gold standard for detecting and removing precancerous polyps.
The next dated milestone on record: the first 400,000 FIT tests begin reaching SUS patients in December, with the program’s expansion tied to each state’s colonoscopy capacity.
References
- UOL — “Câncer de intestino: por que rastreio é aos 45 anos se há jovens doentes?”
- Estadão — “Teste para rastreamento de câncer de intestino começará em dezembro no SUS”
- Correio do Povo — “Com crescimento entre jovens, câncer colorretal tem avanços no rastreamento e desafios para o acesso”
- Rádio Folha PE — interview with oncologist Nildevande Firmino
- Instituto Nacional do Câncer (INCA) — cancer incidence estimates, gov.br/inca
Consult a qualified physician about screening and any symptoms.
Worth a look
- Lee Se-young Credits 8-Kilogram Weight Loss to Low-Carb Diet for ‘The Remarried Empress’ Role
- Memphis Doctors Warn Antibiotic Misuse Fuels Resistance Crisis
- Pope Leo XIV Cleared for South America Tour After Lung Cancer Surgery (newsdirectory3.com)
- Manchester School Tax Cap Recount Begins Nov. 20 After 21-Vote Deficit (news-usa.today)